Ewa Malecka-Panas

Plain English
This study looked at how patients with acute pancreatitis are discharged from the hospital and evaluated a new discharge protocol created in Hungary. Researchers found that 87.5% of medical centers surveyed had no discharge guidelines, and those using a discharge protocol had shorter hospital stays (about 7 days instead of 8) and fewer patients returning for additional treatment (5% readmission rate). This matters because having a standard protocol can improve patient care and efficiency in hospitals. Who this helps: This helps patients with acute pancreatitis by ensuring safer and more effective discharge practices.

Plain English
This study created and tested a new scoring system called the POLPREP scale, which measures how clear the inside of the upper gastrointestinal tract is during a procedure called esophagogastroduodenoscopy (EGD). The researchers found that the POLPREP scale had a high agreement rate between different operators (0.8), and that when the mucosa was clean (scores of 2 and 3), doctors detected lesions in nearly 20% of cases, compared to only about 8% in less clean areas. This is important because better visibility may lead to earlier detection of serious conditions in the digestive system. Who this helps: This helps doctors and patients by improving the accuracy of early diagnosis for upper gastrointestinal issues.

Plain English
The REAPPEAR study researched whether a program to help patients quit smoking and drinking can prevent repeated episodes of acute pancreatitis, which is a painful condition that can lower quality of life. The study involves about 182 patients in each group, with some receiving regular support for quitting and others receiving less frequent check-ins. The goal is to find out if the cessation program reduces the number of people who experience more pancreatitis attacks or die within two years. Who this helps: This helps patients struggling with alcohol and tobacco addiction, especially those with acute pancreatitis.

Plain English
This study examined the genetic factors that might increase the risk of esophageal atresia with or without tracheoesophageal fistula (EA/TEF), a common birth defect affecting the esophagus. Researchers analyzed data from 764 patients and 5,778 healthy individuals, identifying three specific regions in the genome linked to a higher risk of EA/TEF. The findings indicate that certain genetic variants greatly increase the odds of developing this condition, with one variant raising the risk nearly four times. Who this helps: This research benefits patients born with EA/TEF and their families by improving understanding of the genetic risks involved.

Plain English
This study looked at the position of a duodenal diverticulum, an abnormal pouch in the intestine, and its relationship with a key area called the major duodenal papilla in 628 patients who underwent a specific medical procedure. Researchers found that 66 patients (or 10.5%) had diverticula near the papilla, and those with diverticula had a higher chance of developing gallstones after having their gallbladder removed. Understanding these connections is important because it can help doctors manage risks for patients who have these conditions. Who this helps: This helps doctors and patients with duodenal diverticula and gallbladder issues.

Plain English
This study focused on finding ways to predict the risk of developing pancreatic ductal adenocarcinoma (PDAC), a deadly cancer usually diagnosed at an advanced stage. Researchers developed a genetic risk score based on 30 known genetic factors and found that people in the highest risk group were over 14 times more likely to develop PDAC compared to those in the lowest risk group. This research is important because it helps create better tools for identifying individuals at high risk, potentially leading to earlier diagnosis and better survival rates. Who this helps: This benefits patients at risk for pancreatic cancer and their healthcare providers.

Plain English
This study looked at levels of a protein called brain-derived neurotrophic factor (BDNF) in the blood of patients with Crohn's disease (CD) compared to healthy individuals. It found that CD patients had higher BDNF levels than healthy controls (with a significant difference noted), and higher BDNF levels were linked to worse sleep and more pain, but the treatment with anti-TNF-α did not affect BDNF levels. This matters because understanding BDNF could help explain some of the pain and sleep issues that many CD patients experience. Who this helps: This research benefits patients with Crohn's disease and their doctors.

Plain English
This study explored how a new drug, PSB-KK-1415, affects inflammation and pain in the intestines by targeting a receptor called GPR18 in mice models. The researchers found that PSB-KK-1415 significantly reduced inflammation scores and pain-related behaviors in mice with colitis, with reductions in macroscopic scores from 2.61 to 1.79 and 58.00 to 32.60 in pain responses. This is important because it suggests that targeting GPR18 could lead to better treatments for conditions like inflammatory bowel disease and chronic pain. Who this helps: Patients with inflammatory bowel diseases, such as Crohn's disease.

Plain English
This study looked at how certain genetic changes in long noncoding RNAs (lncRNAs) might affect the risk of developing pancreatic cancer, which is expected to become a major cause of cancer deaths. Researchers analyzed nearly 10,000 patients with pancreatic cancer and almost 10,000 healthy individuals. They found a specific genetic change, called rs7046076, that is strongly linked to increased risk; this change may interfere with important cell regulation processes, raising concerns for future cancer development. Who this helps: This helps patients at risk of pancreatic cancer by identifying genetic factors that could inform prevention strategies.

Plain English
This study looked at two substances in the blood, IGF-1 and IGFBP-2, to see if they can help tell the difference between chronic pancreatitis (CP) and pancreatic cancer (PDAC) in people who also have diabetes. The researchers found that IGF-1 levels were significantly higher in patients with CP (81.11 ng/ml) compared to those with PDAC (53.18 ng/ml). Likewise, IGFBP-2 was also higher in CP patients (512.42 ng/ml) than in PDAC patients (301.59 ng/ml). These findings are important because they could provide doctors with better tools to diagnose these two conditions, which often have similar symptoms. Who this helps: This helps patients with pancreatic issues, particularly those showing signs of diabetes.

Plain English
In this study, researchers looked at a compound called AdipoRon to see if it could help protect the stomach from ulcers in mice. They found that AdipoRon reduced ulcer damage significantly when given in doses of 5 and 50 mg/kg, showing better results than the standard treatment omeprazole. This is important because it shows that targeting specific receptors in the stomach could lead to new therapies for preventing ulcers. Who this helps: This research benefits patients at risk of gastric ulcers and doctors seeking effective treatment options.

Plain English
This research paper looks at pancreatic cancer, a very deadly disease that is often diagnosed too late for effective treatment. The study focuses on new potential biomarkers, particularly microRNAs, which may help identify the cancer earlier than current tests. Finding these biomarkers is crucial because earlier detection can lead to better treatment outcomes and helps more patients survive longer. Who this helps: This helps patients with pancreatic cancer and their doctors.

Plain English
This study focused on leukocytapheresis, a treatment that cleans the blood by removing certain white blood cells connected to inflammation. It showed promise for patients with ulcerative colitis who don't respond to standard treatments, as it appears to be safe and may reduce the need for steroids. However, there isn’t enough evidence to determine if it's effective for Crohn's disease, and further research is needed to better understand its impact on these patients. Who this helps: Patients with ulcerative colitis who are searching for new treatment options.

Plain English
This study looked at how certain genetic variations related to mitochondrial function might influence the risk of developing pancreatic cancer. The researchers analyzed genetic data from about 55,870 people, including nearly 13,000 with pancreatic cancer, but found no significant link between these genetic variations and cancer risk. This is important because it suggests that mitochondrial genetics may not play a role in pancreatic cancer development, which could shape future research and treatment approaches. Who this helps: This helps researchers and healthcare professionals focusing on pancreatic cancer.

Plain English
This study looked at how certain genetic variations might influence the risk of developing pancreatic cancer. Researchers analyzed data from over 14,000 pancreatic cancer patients and more than 11,000 healthy individuals to identify specific genetic markers, finding that one particular marker (rs7985480) increased the risk by about 12%. Understanding these genetic factors is important because it can help identify individuals at higher risk for pancreatic cancer, potentially leading to earlier detection and better treatment strategies. Who this helps: Patients at risk for pancreatic cancer.

Plain English
This study looked at how inflammation in the colon affects blood sugar levels and the role of a hormone called GLP-1 in Crohn's disease (CD). The research found that, while blood sugar levels were higher in mice with colitis, GLP-1 levels were lower in their blood and higher in their colon tissue. This indicates that changes in the incretin system could play a role in managing blood sugar issues associated with CD, suggesting potential new treatment approaches. Who this helps: This helps patients with Crohn's disease.

Plain English
This study looked into the genetic factors that might increase the risk of pancreatic cancer. Researchers analyzed data from nearly 9,000 people with pancreatic cancer and over 7,000 without, finding six genetic variants linked to the disease, particularly rs4626538, rs7008921, and rs147904962. Although these genetic variants didn't meet the strict criteria of being major risk factors on their own, they highlight the importance of looking for additional genetic influences on pancreatic cancer risk that may not be detected with traditional methods. Who this helps: This research benefits patients at risk for pancreatic cancer by improving ways to identify their genetic susceptibility.

Plain English
This study looked at how a substance called mannose-binding lectin (MBL) might be involved in inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC). Researchers found that people with CD had higher levels of MBL when they carried a certain gene variant, showing levels of 1493 ng/ml compared to 800 ng/ml in healthy individuals, indicating that MBL may play a role in the inflammation seen in CD. Understanding this relationship could help target more effective treatments for inflammation in IBD patients. Who this helps: This helps patients with inflammatory bowel disease.

Plain English
Researchers studied levels of two proteins, IGF-1 and IGFBP-2, in the blood of patients with pancreatic cancer (specifically pancreatic adenocarcinoma) and compared them to healthy individuals. They found that patients with cancer had lower levels of IGF-1 (around 46 ng/mL) and much higher levels of IGFBP-2 (about 225 ng/mL). The ratio of these two proteins can indicate the presence of pancreatic cancer, with a ratio below 0.85 being particularly telling. Who this helps: This information benefits doctors and helps with early detection of pancreatic cancer.

Plain English
This study looked at a patient with Crohn's disease who developed lung problems, specifically exfoliative interstitial pneumonitis, likely due to long-term use of a medication called mesalazine. The patient had a history of pneumonia but was a non-smoker, making the lung issue harder to diagnose. After a lung biopsy, it was confirmed that the medication was causing the problem, and stopping the medication led to improvement in the patient’s condition. Who this helps: This information is helpful for doctors treating patients with Crohn's disease and those taking mesalazine.

Plain English
Researchers studied the genetic factors that increase the risk of early onset pancreatic cancer (EOPC), a serious and rare disease that often affects people under 60. They identified a specific genetic variant, rs2328991, that is linked to EOPC risk after examining genetic data from 821 young patients and 3,227 healthy individuals. This finding is important because it helps us understand the genetic risks of EOPC, which can lead to earlier detection and better management of the disease. Who this helps: This helps patients with early onset pancreatic cancer and their doctors in terms of understanding their risk.

Plain English
This study looked at how effective and safe a treatment for Crohn's disease called anti-TNF-α therapy is when given for one year. Out of 80 patients, 67.5% achieved good improvement after one year, but 20% faced serious side effects, such as severe infections. The findings show that the limited time for treatment can lead to patients needing to restart therapy sooner, impacting their health management. Who this helps: This helps patients with Crohn's disease.

Plain English
This study looked at two proteins, activin A and myostatin, in patients with pancreatic cancer and how they relate to weight loss. Out of 93 patients studied, about 62% experienced significant weight loss, with higher levels of activin A found in those with advanced cancer compared to those with earlier stages and healthy controls. This finding is important because high levels of activin A may help doctors identify patients with metastatic pancreatic cancer who are suffering from weight loss. Who this helps: This helps patients with pancreatic cancer and their doctors.

Plain English
This study analyzed the GPRC6A gene to see if its variations are linked to different types of pancreatitis, particularly focusing on alcoholic chronic pancreatitis. The researchers examined genetic information from over 1,100 patients and nearly 2,000 control subjects and found a connection between one specific gene variant (rs1606365) and a lower risk of alcoholic chronic pancreatitis in German and Chinese groups. These findings emphasize the role of calcium regulation and inflammation in developing this type of pancreatitis, suggesting further research could clarify these mechanisms. Who this helps: This benefits patients with alcoholic chronic pancreatitis and researchers looking for targeted treatments.

Plain English
This study looked at sleep quality in patients with inflammatory bowel diseases (IBD) and found that they generally sleep worse than healthy people. In fact, IBD patients reported more sleep issues across all questionnaires used, with scores indicating worse sleep quality (p-values < 0.001). Those experiencing flare-ups had poorer sleep quality than those in remission, and mood levels were identified as a key factor affecting their sleep. Who this helps: This research benefits IBD patients and their healthcare providers by highlighting the need for better management of sleep issues related to their condition.

Plain English
This study looked at the use of acid-suppressing drugs (ASDs) in over 17,000 patients with acute pancreatitis from around the world. It found that while many patients (86.6%) were given these drugs during their treatment, this was linked to more severe cases of pancreatitis and higher death rates. The research suggests that using ASDs may not help patients recover and may actually lead to complications like gastrointestinal bleeding and infections. Who this helps: This information benefits patients and doctors by highlighting the risks of using acid-suppressing drugs in acute pancreatitis treatment.

Plain English
This study looked at the blood clotting factors in 93 patients with newly diagnosed pancreatic cancer, comparing those with early-stage disease to those with advanced (metastatic) cancer and a group of healthy individuals. Researchers found that all patients had elevated levels of tissue factor (TF), and those with metastatic cancer had significantly higher levels of TF and thrombin-antithrombin complex (TAT) compared to those without metastases and healthy controls. These findings highlight that blood clotting issues are common in pancreatic cancer patients at diagnosis and worsen as the disease progresses, which is important for understanding the disease's impact and managing patient care. Who this helps: This information helps doctors treating patients with pancreatic cancer.

Plain English
This study looked at the role of specific receptors, called FFAR3 and FFAR4, in people with gastroesophageal reflux disease (GERD), which can occur in two forms: erosive (ERD) and nonerosive (NERD). Researchers found that patients with GERD had higher levels of FFARs compared to healthy individuals, especially those with nonerosive GERD, who had higher levels than those with erosive GERD. This matters because understanding these receptors might help develop new ways to diagnose and treat GERD. Who this helps: This helps patients suffering from gastroesophageal reflux disease.

Plain English
This study looked at how certain substances, called adipokines, can help doctors assess the severity of acute pancreatitis (a serious inflammation of the pancreas) and predict how the disease will progress. It found that specific adipokines, particularly interleukin 6, neutrophil gelatinase-associated lipocalin, and resistin, are the most useful for diagnosis and predicting outcomes in patients with acute pancreatitis. Understanding these markers is important because they could improve early diagnosis and treatment, potentially reducing complications and improving patient care. Who this helps: This benefits patients with acute pancreatitis and their doctors.

Plain English
This study explored how serotonin affects abdominal pain and inflammation in mice with colitis, a type of inflammatory bowel disease (IBD). Researchers found that giving mice serotonin made their pain worse and increased inflammation. Specifically, after five days of treatment, the pain response increased significantly, and levels of a comfort signaling molecule called anandamide dropped. This study is important because it highlights a connection between serotonin and pain mechanisms in IBD, suggesting that targeting serotonin could help those with severe abdominal pain. Who this helps: Patients with inflammatory bowel disease experiencing severe abdominal pain.

Plain English
This study looked at two rare genetic mutations, BRCA2 K3326X and CHEK2 I157T, to see if they increase the risk of developing pancreatic cancer in people without a family history of the disease. Researchers tested DNA from nearly 3,000 pancreatic cancer patients and over 5,600 healthy individuals, finding that those with the K3326X mutation had a 78% higher risk and those with the I157T mutation had a 74% higher risk of developing pancreatic cancer compared to those without these mutations. These findings are important because they could help identify individuals who are at higher risk for pancreatic cancer and might benefit from earlier screening or prevention strategies. Who this helps: This helps patients and families at risk of pancreatic cancer.

Plain English
This study focused on improving how pancreatic ductal adenocarcinoma (PDAC) is diagnosed and treated, a type of cancer known for being very aggressive with a poor outlook for patients. The researchers gathered insights from various reputable guidelines and expert opinions to create clear recommendations for diagnosing and treating PDAC, covering everything from surgery to palliative care. These recommendations are based on clinical studies and received approval from members of the Polish Pancreatic Club. Who this helps: This helps doctors and healthcare providers who treat patients with pancreatic cancer.

Plain English
This study looked at how common anaemia (a lack of healthy red blood cells) is among patients recently diagnosed with inflammatory bowel disease (IBD). It found that 65.4% of these patients had anaemia, with higher rates in women and those with more severe forms of the disease. The presence of anaemia also meant patients spent more time in the hospital—about 8 days for those with Crohn's disease compared to about 6 days for those without anaemia. Who this helps: This helps patients with IBD and their doctors by highlighting the importance of monitoring anaemia during diagnosis and treatment.

Plain English
This research looked at how a specific estrogen receptor, called GPER, affects Crohn's disease, an inflammatory bowel condition. The study found that activating GPER can lower inflammation, reduce mortality in affected individuals, and improve overall health markers in mice with Crohn's disease. Specifically, activating GPER resulted in lower levels of a protein linked to inflammation and improved health scores in the mice. Who this helps: This benefits patients with Crohn's disease by offering a potential new treatment target for managing their symptoms.

Plain English
This study looked at how antibiotics are used in patients with acute pancreatitis, a condition where the pancreas becomes inflamed. Researchers found that nearly one-third to over 80% of patients received antibiotics even when they might not need them, and common lab tests used to decide on antibiotic treatment were not effective in predicting infections. Instead, measuring procalcitonin levels is a better way to identify infections early, and the researchers recommend using this method to reduce unnecessary antibiotic use, which is important because it can help prevent antibiotic resistance. Who this helps: This helps doctors and patients by ensuring more accurate treatment and reducing the risk of antibiotic overuse.

Plain English
This study looked at how estrogen receptors in the body affect inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis. Researchers found that men with these conditions showed higher levels of certain estrogen receptors, while women had varied responses based on their age; for example, younger women had increased levels of one receptor but decreased levels of another. Understanding these differences is important because it highlights how estrogen signaling can influence immune responses in IBD, which could lead to more tailored treatments. Who this helps: This helps patients with inflammatory bowel diseases, particularly those who are men or women in specific age groups.

Plain English
This study looked at whether common genetic variations in a gene called Glyoxalase I (GLO1) are linked to the risk of developing chronic pancreatitis, both from alcohol and other causes. Researchers analyzed genetic samples from 1,441 patients and found no significant connection; for example, the genetic variant rs1937780 showed a p-value of 0.11, which means there was no strong evidence of a link to chronic pancreatitis. This matters because it helps clarify that these common GLO1 variants do not play a role in increasing the risk of this disease, which can help shape future research and treatment approaches. Who this helps: This helps patients at risk of chronic pancreatitis and doctors who treat them.

Plain English
This study looked at how well biosimilar drugs work for treating inflammatory bowel diseases (IBDs) like Crohn's disease and ulcerative colitis compared to original drugs. Researchers found that these biosimilars, which are similar to the original treatments, are just as effective and safe. Using biosimilars can lower costs significantly, allowing more patients to receive treatment. Who this helps: This helps patients with inflammatory bowel diseases by providing more affordable treatment options.

Plain English
This study looked at how certain genetic variations might increase the risk of acute pancreatitis (AP), a painful condition that often sends people to the hospital. Researchers analyzed data from over 1,400 AP patients and almost 4,000 healthy individuals, finding that certain genes were linked to AP: one variant (rs10273639) appeared to lower risk, while two others (rs7057398 and rs12688220) were associated with a higher risk, especially in patients who drink alcohol. Understanding these genetic links could help identify individuals at risk for AP, allowing for earlier interventions. Who this helps: This research benefits patients at risk of acute pancreatitis, particularly those who consume alcohol.

Plain English
This study looked at how certain proteins related to insulin, called the IGF axis, could help in the early diagnosis of pancreatic cancer in people who recently developed diabetes. Researchers found that new-onset diabetes, especially in people over 50, significantly raises the risk of pancreatic cancer, and measuring IGF-1 levels may help with early detection. This matters because catching pancreatic cancer early can lead to better treatment outcomes. Who this helps: This helps patients with new diabetes symptoms and their doctors.

Plain English
This study looked at how irritable bowel syndrome (IBS) affects patients' quality of life and mental health, focusing on symptoms of depression. Researchers tested 87 IBS patients and 56 healthy individuals, finding that those with IBS had significantly higher depression scores and lower quality of life across various aspects, including emotional well-being and social relationships. Specifically, women with IBS reported lower quality of life compared to men, and older IBS patients worried more about their health. Who this helps: This research benefits IBS patients by highlighting the need for mental health assessments during treatment.

Plain English
This research paper outlines updated guidelines for diagnosing and treating chronic pancreatitis, which is a long-lasting inflammation of the pancreas. The recommendations cover various aspects, such as managing pain and supporting both digestive and hormonal functions of the pancreas, and were reviewed and voted on by experts, with ratings showing strong approval for most recommendations. These updates are important because they aim to improve patient care and outcomes over previous guidelines from 2011 by ensuring that the latest research is reflected in practice. Who this helps: This helps patients with chronic pancreatitis by providing them with better treatment options.

Plain English
This paper updates the guidelines for managing irritable bowel syndrome (IBS) based on new research since 2008. The findings highlight important information about the causes, symptoms, and treatment options for IBS, helping healthcare providers improve their diagnosis and care for patients. For example, recent studies have offered clearer criteria for identifying the condition and better strategies for treatment. Who this helps: This helps patients and doctors by providing clearer guidelines for diagnosing and managing IBS.

Plain English
This study looked at how different factors, like age and education, affect how well people with ulcerative colitis (UC) come to terms with their condition. It involved 50 patients, mainly young adults with an average age of about 39. Overall, the patients scored an average of 29.65 on an acceptance scale, indicating a moderate level of acceptance, but those experiencing flare-ups had a harder time accepting their illness. Notably, patients with higher education and those who were working found it easier to cope with their disease. Who this helps: This research benefits patients with ulcerative colitis by highlighting factors that can improve their acceptance of the disease.